These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22503877)

  • 1. Serum lysophosphatidylcholine level is not altered in coronary artery disease.
    Song SH; Yoon Y; Park KU; Song J; Kim JQ
    Clin Biochem; 2012 Jul; 45(10-11):793-7. PubMed ID: 22503877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of lysophosphatidylcholines and phosphatidylcholines using liquid chromatography-tandem mass spectrometry in neonatal serum.
    Takatera A; Takeuchi A; Saiki K; Morisawa T; Yokoyama N; Matsuo M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):31-6. PubMed ID: 16603422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
    Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
    J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Ménégaut L; Masson D; Abello N; Denimal D; Truntzer C; Ducoroy P; Lagrost L; Pais de Barros JP; Athias A; Petit JM; Martin L; Steinmetz E; Kretz B
    Atherosclerosis; 2016 Aug; 251():339-347. PubMed ID: 27189320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
    Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
    Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate.
    Deutschman DH; Carstens JS; Klepper RL; Smith WS; Page MT; Young TR; Gleason LA; Nakajima N; Sabbadini RA
    Am Heart J; 2003 Jul; 146(1):62-8. PubMed ID: 12851609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipidomic analysis of stable and unstable coronary artery disease.
    Meikle PJ; Wong G; Tsorotes D; Barlow CK; Weir JM; Christopher MJ; MacIntosh GL; Goudey B; Stern L; Kowalczyk A; Haviv I; White AJ; Dart AM; Duffy SJ; Jennings GL; Kingwell BA
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2723-32. PubMed ID: 21903946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of lysophosphatidylcholine species by high-throughput electrospray ionization tandem mass spectrometry (ESI-MS/MS).
    Liebisch G; Schmitz G
    Methods Mol Biol; 2009; 580():29-37. PubMed ID: 19784593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and lipid levels in young patients with coronary artery disease.
    Puri A; Gupta OK; Dwivedi RN; Bharadwaj RP; Narain VS; Singh S
    J Assoc Physicians India; 2003 Jul; 51():681-5. PubMed ID: 14621037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and high molecular weight adiponectin in patients with coronary artery disease.
    El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY.
    Kadoglou NP; Lampropoulos S; Kapelouzou A; Gkontopoulos A; Theofilogiannakos EK; Fotiadis G; Kottas G
    Transl Res; 2010 May; 155(5):238-46. PubMed ID: 20403579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes.
    Shi AH; Yoshinari M; Wakisaka M; Iwase M; Fujishima M
    Horm Metab Res; 1999 Apr; 31(4):283-6. PubMed ID: 10333086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.